… immunomodulatory drugs administered to treat COVID-19 or alleviate its symptoms. It also
tries to investigate the possible mechanism of action … critical immunomodulatory agents from …

… Cytokines via Immunomodulatory Drugs and Immunotherapeutics The most sagacious treatment
method to control the serious effects of COVID-19 is to … Various immunomodulators and …

… immunopathology being a hallmark of severe disease. Herein, we outline the various routes
involved in the immunopathology of COVID-19 … Immunomodulators have been widely used …

… mechanism of COVID-19 is still sparse, however, the similarity between COVID-19 with
SARS-CoV and MERS-CoV may allow us to understand possible mechanisms of COVID-19 [2]. …

… mechanisms, and thereby provide a more stable niche. Overall, combination of detrimental
immunostimulatory and immunomodulatory … COVID-19 patients admitted to the intensive care …

… like pulmonary immunopathology characteristic of COVID-19, above … and non-specific
immunomodulating agents, including … in the management of severe COVID-19, and their impact on …

… in COVID-19 patients compared with a group treated only … and immunomodulatory compound
used to treat influenza and … supports the potential use of arbidol to treat COVID-19 (315). …

… However, many researches are underway to clarify the role of antiviral and immunomodulating
drugs in changing morbidity and mortality in patients who become severely ill. This …

… Here, we summarize current knowledge on COVID-19 … We also discuss how knowledge
of immunopathology may … intervention with immunomodulatory drugs is likely critical. …

… in treatment of those patients. Therapeutic strategy should therefore be based on viral kinetics
and the immunopathology of COVID-19. … may benefit from immunomodulatory treatment. …